Cargando…
An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers
Background: Systemic inflammatory indicators are clinically significant in guiding diffuse large B-cell lymphoma (DLBCL) prognosis. However, which inflammatory markers are the best predictors of DLBCL prognosis is still unclear. In this study, we aimed to create a nomogram based on the best inflamma...
Autores principales: | Liu, Yajiao, Sheng, Li, Hua, Haiying, Zhou, Jingfen, Zhao, Ying, Wang, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408319/ https://www.ncbi.nlm.nih.gov/pubmed/37551117 http://dx.doi.org/10.1177/15330338231180785 |
Ejemplares similares
-
A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
por: Liu, Yajiao, et al.
Publicado: (2023) -
Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma
por: Deng, Hongyan, et al.
Publicado: (2022) -
Development and validation of a novel nomogram for predicting overall survival in gastric cancer based on inflammatory markers
por: Luo, Pan-Quan, et al.
Publicado: (2023) -
Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma
por: Zhi, Yongjin, et al.
Publicado: (2023) -
Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer
por: Wang, Shuanhu, et al.
Publicado: (2021)